Goh, N.L.L.-A.; Abdul Rahim, N.J.; Bhatt, R.; Ong, S.E.; Lim, K.Y.; Gandini, A.; Zeng, Z.; Kumari, S.; Gabrielli, B.
Checkpoint Kinase 1 Inhibitor Combined with Low Dose Hydroxyurea Promotes ATM-Activated NF-κB-Dependent Pro-Inflammatory Chemokine Expression in Melanomas. Cancers 2025, 17, 1817.
https://doi.org/10.3390/cancers17111817
AMA Style
Goh NLL-A, Abdul Rahim NJ, Bhatt R, Ong SE, Lim KY, Gandini A, Zeng Z, Kumari S, Gabrielli B.
Checkpoint Kinase 1 Inhibitor Combined with Low Dose Hydroxyurea Promotes ATM-Activated NF-κB-Dependent Pro-Inflammatory Chemokine Expression in Melanomas. Cancers. 2025; 17(11):1817.
https://doi.org/10.3390/cancers17111817
Chicago/Turabian Style
Goh, Nicole Lisa Li-Ann, Nur Jannah Abdul Rahim, Rituparna Bhatt, Si En Ong, Khai Yee Lim, Anastasia Gandini, Zhen Zeng, Snehlata Kumari, and Brian Gabrielli.
2025. "Checkpoint Kinase 1 Inhibitor Combined with Low Dose Hydroxyurea Promotes ATM-Activated NF-κB-Dependent Pro-Inflammatory Chemokine Expression in Melanomas" Cancers 17, no. 11: 1817.
https://doi.org/10.3390/cancers17111817
APA Style
Goh, N. L. L.-A., Abdul Rahim, N. J., Bhatt, R., Ong, S. E., Lim, K. Y., Gandini, A., Zeng, Z., Kumari, S., & Gabrielli, B.
(2025). Checkpoint Kinase 1 Inhibitor Combined with Low Dose Hydroxyurea Promotes ATM-Activated NF-κB-Dependent Pro-Inflammatory Chemokine Expression in Melanomas. Cancers, 17(11), 1817.
https://doi.org/10.3390/cancers17111817
